Nan Geng

机构：Hebei Medical University, Fourth Hospital of Hebei Medical University · ORCID：0000-0001-8953-1438

发表论文 23 篇 · 总被引 256 次 · h-index 8

代表论文

• Crenolanib, a PDGFR inhibitor, suppresses lung cancer cell proliferation and inhibits tumor growth in vivo (2014 · OncoTargets and Therapy · 被引 41)
• MicroRNA‑145 inhibits migration and induces apoptosis in human non‑small cell lung cancer cells through regulation of the EGFR/PI3K/AKT signaling pathway (2018 · Oncology Reports · 被引 37)
• AKR1B10 Inhibitor Epalrestat Facilitates Sorafenib-Induced Apoptosis and Autophagy Via Targeting the mTOR Pathway in Hepatocellular Carcinoma (2020 · International Journal of Medical Sciences · 被引 36)
• Evaluation of circulating small extracellular vesicle-derived miRNAs as diagnostic biomarkers for differentiating between different pathological types of early lung cancer (2022 · Scientific Reports · 被引 32)
• Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR (2018 · Oncology Reports · 被引 22)
• Chinese tuina downregulates the elevated levels of tissue plasminogen activator in sciatic nerve injured Sprague-Dawley rats (2015 · Chinese Journal of Integrative Medicine · 被引 21)